Page 35 - JCTR-10-1
P. 35

Shah et al. | Journal of Clinical and Translational Research 2024; 10(1): 25-32   31
        5. Conclusions                                          [5]   Danan G, Teschke R. RUCAM in Drug and Herb Induced
                                                                      Liver Injury: The Update. Int J Mol Sci 2015;17:14.
          A short course (a few weeks) of steroids can  be used to
        effectively treat DILI and intractable pruritus in patients without      doi: 10.3390/ijms17010014
        liver failure. However, large prospective controlled  studies are   [6]   Bent S, Ko R. Commonly Used Herbal Medicines in the
        needed to confirm the role of corticosteroids in these situations.  United States: A Review. Am J Med 2004;116:478-85.
                                                                      doi: 10.1016/j.amjmed.2003.10.036
        Acknowledgments                                         [7]   Philips  CA,  Paramaguru  R,  Joy  AK,  Antony  KL,
          None.                                                       Augustine  P. Clinical  Outcomes, Histopathological
                                                                      Patterns,  and Chemical  Analysis of  Ayurveda  and
        Funding                                                       Herbal Medicine Associated with Severe Liver Injury-A
          None.                                                       Single-center  Experience  from  Southern  India.  Indian  J
                                                                      Gastroenterol 2018;37:9-17.
        Conflicts of Interest                                         doi: 10.1007/s12664-017-0815-8
          The authors declare no conflicts of interest.         [8]   Navarro  VJ,  Barnhart  H,  Bonkovsky  HL,  Davern  T,
                                                                      Fontana RJ, Grant L,  et al. Liver Injury from Herbals
        Ethics Approval and Consent to Participate                    and Dietary Supplements in the U.S. Drug-induced Liver
                                                                      Injury Network. Hepatology 2014;60:1399-408.
          As  this study was retrospective in nature, research ethics
        approval was not obtained. However, written informed consent      doi: 10.1002/hep.27317
        was obtained from all patients for inclusion in the study.  [9]   Petrovic A, Vukadin  S,  Sikora  R,  Bojanic  K,  Smolic  R,
                                                                      Plavec D, et al. Anabolic Androgenic Steroid-induced Liver
        Consent for Publication                                       Injury: An Update. World J Gastroenterol 2022;28:3071-80.

          Written informed consent was obtained from all patients for      doi: 10.3748/wjg.v28.i26.3071
        using their data in a publication.                      [10]  Devarbhavi H, Raj S, Joseph T, Singh R, Patil M. Features
                                                                      and  Treatment  of  Dapsone-induced  Hepatitis,  based
        Availability of data                                          on  Analysis of 44 Cases and Literature  Review. Clin

          Data are available from the corresponding author on reasonable   Gastroenterol Hepatol 2017;15:1805-7.
        request.                                                      doi: 10.1016/j.cgh.2017.05.031
                                                                [11]  Zhou ZX, Yin XD, Zhang Y, Shao QH, Mao XY, Hu WJ,
        References                                                    et  al. Antifungal  Drugs and Drug-induced Liver  Injury:

        [1]   Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR,    A  Real-World  Study Leveraging  the  FDA  Adverse
             Practice Parameters Committee of the American College of   Event  Reporting  System  Database.  Front  Pharmacol
             Gastroenterology. ACG Clinical Guideline: Diagnosis and   2022;13:891336.
             Management of Idiosyncratic Drug-induced Liver Injury.      doi: 10.3389/fphar.2022.891336
             Am J Gastroenterol 2021;116:878-98.                [12]  Raschi  E,  Poluzzi  E,  Koci  A,  Caraceni  P,  De  Ponti  F.
             doi: 10.14309/ajg.0000000000001259                       Assessing Liver Injury  Associated  with  Antimycotics:
        [2]   Devarbhavi H. Drug-induced Liver Injury Unique to India.   Concise Literature Review and Clues from Data Mining of
             Clin Liver Dis (Hoboken) 2021;18:108-10.                 the FAERS Database. World J Hepatol 2014;6:601-12.
             doi: 10.1002/cld.1120                                    doi: 10.4254/wjh.v6.i8.601
        [3]   Brahmer JR, Lacchetti  C, Schneider BJ,  Atkins MB,   [13]  Sandhu  N,  Navarro V.  Drug-induced  Liver  Injury  in  GI
             Brassil KJ, Caterino JM, et al. Management of Immune-    Practice. Hepatol Commun 2020;4:631-45.
             related Adverse Events in Patients Treated with Immune      doi: 10.1002/hep4.1503
             Checkpoint  Inhibitor  Therapy:  American  Society  of   [14]  Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-
             Clinical  Oncology Clinical  Practice  Guideline.  J  Clin   Ublick GA, Watkins PB, et al. Drug-induced Liver Injury.
             Oncol 2018;36:1714-68.                                   Nat Rev Dis Primers 2019;5:58.
             doi: 10.1200/JCO.2017.77.6385                            doi: 10.1038/s41572-019-0105-0
        [4]   Björnsson  ES,  Bergmann  O,  Jonasson  JG,  Grondal  G,   [15]  European Association for the Study of the Liver, Clinical
             Gudbjornsson B, Olafsson S. Drug-induced Autoimmune      Practice  Guidelines  Panel,  Wendon J, Panel Members,
             Hepatitis: Response to Corticosteroids and Lack of Relapse   Cordoba J, Dhawan  A,  et al.  EASL  Clinical  Practical
             After  Cessation of Steroids.  Clin  Gastroenterol  Hepatol   Guidelines on the Management of Acute (Fulminant) Liver
             2017;15:1635-6.                                          Failure. J Hepatol 2017;66:1047-81.
             doi: 10.1016/j.cgh.2017.05.027                           doi: 10.1016/j.jhep.2016.12.003
                                                DOI: https://doi.org/10.36922/jctr.00104
   30   31   32   33   34   35   36   37   38   39   40